ストックスクリーナーアプリを入手
0.5499
4.62%
-0.0175
アフターアワーズ：
.55
0.000100
+0.02%
前日終値:
$0.5674
開ける：
$0.585
24時間の取引高:
88,941
Relative Volume:
0.65
時価総額：
$6.71M
収益：
$152.40K
当期純損益:
$-10.52M
株価収益率:
-0.1417
EPS:
-3.88
ネットキャッシュフロー:
$-4.26M
1週間 パフォーマンス:
-1.78%
1か月 パフォーマンス:
+0.22%
6か月 パフォーマンス:
-49.89%
1年 パフォーマンス:
-69.60%
1日の値動き範囲:
$0.53
$0.59
1週間の範囲:
$0.50
$0.59
52週間の値動き範囲:
$0.4053
$2.45
Abvc Biopharma Inc Stock (ABVC) Company Profile
名前
Abvc Biopharma Inc
セクター
電話
510-668-0881
住所
44370 OLD WARM SPRINGS BLVD., FREMONT
ABVC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| ABVC | 0.5499 | 6.71M | 152.40K | -10.52M | -4.26M | -3.88 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Abvc Biopharma Inc (ABVC) 最新ニュース
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024 - Defense World
ABVC BioPharma Inc. (ABVC) Quarterly 10-Q Report - Quartzy
ABVCABVC BioPharma, Inc. Latest Stock News & Market Updates - StockTitan
ABVC BioPharma Reports First Operational Profit in Q3 2024, Showcasing Significant Financial Improvement - Citybuzz
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones - The Manila Times
ABVC BioPharma Reports First-Ever Operational Profit, 2,352% Revenue Surge in Q3 | ABVC Stock News - StockTitan
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest - Defense World
ABVC BioPharma Enters into Agreement to Exercise Warrants at Reduced Price - Defense World
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
ABVC BioPharma secures additional licensing fees - Investing.com
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners - The Manila Times
ABVC BioPharma secures additional licensing fees By Investing.com - Investing.com UK
ABVC BioPharma switches to new independent accounting firm - Investing.com
ABVC BioPharma switches to new independent accounting firm By Investing.com - Investing.com UK
ABVC BioPharma Inc (ABVC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World
1832 Asset Management L.P. Has $21.08 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Avidity Biosciences initiated with a Buy at Goldman Sachs - TipRanks
ABB unveils number of investors with maximum and minimum stakes in shares - Trend News Agency
ABB (NYSE:ABBNY) Stock Price Passes Above 200 Day Moving Average of $52.74 - MarketBeat
Rhumbline Advisers Sells 495,177 Shares of Ambev S.A. (NYSE:ABEV) - Defense World
Abans Holdings shares: Aditya Birla Money estimates small-cap stock to give multibagger returns. Buy or avoid? | Stock Market News - Mint
ABB (NYSE:ABBNY) Shares Cross Above 200 Day Moving Average of $52.74 - Defense World
Abbott Laboratories (NYSE:ABT) Shares Up 0.3% - MarketBeat
Bank of Montreal Can Trims Stock Holdings in Abbott Laboratories (NYSE:ABT) - Defense World
J. Stern & Co. LLP Has $30.67 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abbott Laboratories (NYSE:ABT) Shares Acquired by Frank Rimerman Advisors LLC - Defense World
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Xponance Inc. Has $24.89 Million Position in Abbott Laboratories (NYSE:ABT) - Defense World
Abans Holdings Limited gets buy call with target price of Rs 710 | Check details here - India.com
Asset Management Firm Abans Holdings Gets Buy Rating from Aditya Birla MoneyKnow Share Price Target - Times Now
DRW Securities LLC Sells 4,279 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Profund Advisors LLC Sells 114 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Sold by Davidson Kempner Capital Management LP - Defense World
It makes sense and dollars to buy ArriVent BioPharma Inc. (AVBP) stock - SETE News
Addus HomeCare price target raised to $145 from $140 at Oppenheimer - TipRanks
American Century Companies Inc. Has $9.70 Million Position in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
AB Capital breaks out from inverse Head & Shoulder pattern; time to buy? - The Economic Times
ProShare Advisors LLC Acquires 127,133 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Heron Bay Capital Management - Defense World
Is AbbVie (NYSE:ABBV) A Risky Investment? - Yahoo Finance
ABIVAX Société Anonyme (NASDAQ:ABVX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Huber Capital Management LLC Has $1.62 Million Stock Holdings in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Callan Capital LLC - Defense World
Abbott Laboratories (NYSE:ABT) Shares Purchased by Ensign Peak Advisors Inc - MarketBeat
Anheuser-Busch InBev SA/NV (NYSE:BUD) Stake Increased by Moors & Cabot Inc. - Defense World
XTX Topco Ltd Invests $2.09 Million in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Envestnet Asset Management Inc. Has $35.56 Million Position in Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
Ieq Capital LLC Purchases 2,154 Shares of Abbott Laboratories (NYSE:ABT) - Defense World
AbbVie’s Elahere gets CHMP nod as competition advances - BioCentury
Abvc Biopharma Inc (ABVC) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.56%
大文字化:
|
ボリューム (24 時間):